Position in BCYC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$46
-$93 QoQ
Shares Held
10
-44.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BCYC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026OSAIC HOLDINGS, INC. holds $166,774,546 across 402 Biotechnology names. BCYC ranks #368 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
43,972 | $19,635,254 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
217,084 | $16,120,657 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
46,653 | $15,436,076 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
183,486 | $11,858,698 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
58,150 | $11,609,647 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,238 | $9,455,565 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
271,608 | $9,022,817 | |
| 8 | ABUS |
Arbutus Biopharma Corp
|
1,348,127 | $6,066,571 |
All Filings in BCYC
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $46 | 10 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $139 | 18 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $125 | 18 | Shares | Defined | 2025-09-04 | |
| 2025-03-31 | $152 | 18 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $10,640 | 760 | Shares | Defined | 2025-06-06 | |
| 2024-09-30 | $23,580 | 1,042 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $25,482 | 1,259 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $34,586 | 1,389 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $35,851 | 1,983 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $67,260 | 3,348 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $59,206 | 2,320 | Shares | Defined | 2023-08-21 | |
| 2023-03-31 | $22,546 | 1,060 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $38,776 | 1,310 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $32,796 | 1,410 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $15,941 | 950 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $177,231 | 4,039 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $263,810 | 4,334 | Shares | Defined | 2022-02-03 | |
| 2021-09-30 | $210,611 | 5,064 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $552,430 | 18,196 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $466,778 | 15,627 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $396,910 | 22,112 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $497,205 | 26,100 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $536,734 | 34,100 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,365 | 100 | Shares | Defined | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||